Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:57 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: | NSE:

Zota Health Care Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹404.28Overvalued by 63.77%vs CMP ₹1,116.00

P/E (15.0) × ROE (36.0%) × BV (₹93.50) × DY (0.09%)

Defaults: P/E=15

₹141.20Overvalued by 87.35%vs CMP ₹1,116.00
MoS: -690.4% (Negative)Confidence: 55/100 (Moderate)Models: All 4: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹207.9439%Over (-81.4%)
Net Asset ValueAssets₹92.7624%Over (-91.7%)
EV/EBITDAEnterprise₹77.2020%Over (-93.1%)
Revenue MultipleRevenue₹128.5718%Over (-88.5%)
Consensus (4 models)₹141.20100%Overvalued
Key Drivers: EPS CAGR -48.6% drags value — could be higher if earnings stabilize.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -48.6% · Defaults: P/E=15

*Investments are subject to market risks

Investment Snapshot

62
Zota Health Care Ltd scores 62/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health63/100 · Moderate
ROCE 17.0% GoodROE 36.0% ExcellentD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent
Smart Money70/100 · Strong
FII holding up 7.22% (6mo) AccumulatingDII holding up 4.14% MF buyingPromoter decreased by 5.17% Caution
Earnings Quality40/100 · Moderate
OPM contracting (8% → 1%) Declining
Quarterly Momentum80/100 · Strong
Revenue (4Q): +93% YoY AcceleratingOPM: 0.0% (up 8.0% YoY) Margin expansion
Industry Rank70/100 · Strong
ROCE 17.0% vs industry 16.4% AverageROE 36.0% vs industry 15.2% Above peers3Y sales CAGR: 31% High growth

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:57 am

Market Cap 3,802 Cr.
Current Price 1,116
Intrinsic Value₹141.20
High / Low 1,740/752
Stock P/E
Book Value 93.5
Dividend Yield0.09 %
ROCE17.0 %
ROE36.0 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Zota Health Care Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Zota Health Care Ltd 3,802 Cr. 1,116 1,740/752 93.50.09 %17.0 %36.0 % 10.0
Suven Life Sciences Ltd 3,888 Cr. 147 303/115 12.40.00 %87.0 %87.2 % 1.00
SMS Pharmaceuticals Ltd 3,678 Cr. 393 434/17542.1 81.20.10 %12.2 %11.0 % 1.00
Aarti Drugs Limited 3,162 Cr. 346 575/31217.0 1470.58 %13.5 %13.0 % 10.0
RPG Life Sciences Ltd 3,105 Cr. 1,878 2,725/1,73129.6 3351.07 %32.8 %25.5 % 8.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Zota Health Care Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 35373945475056677297104129143
Expenses 35363741445158687895100123143
Operating Profit 01143-1-1-1-6246-0
OPM % 0%3%3%10%7%-3%-2%-1%-8%3%4%5%-0%
Other Income 1100000111122
Interest 1111123323345
Depreciation 3435578101114151922
Profit before tax -3-3-3-1-3-10-12-13-18-14-13-14-26
Tax % -4%-15%1%49%7%-27%5%-4%2%-10%5%13%14%
Net Profit -3-3-3-2-3-7-13-12-19-13-14-16-30
EPS in Rs -1.28-1.05-1.13-0.64-1.14-2.68-4.79-4.41-6.78-4.50-4.81-5.20-8.73

Last Updated: March 3, 2026, 1:42 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 12:16 pm

MetricMar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 253850568595106131139180292473
Expenses 213343477790105116132173298460
Operating Profit 45688511578-612
OPM % 14%13%13%15%9%5%1%11%5%4%-2%3%
Other Income 000022222125
Interest 01110000351116
Depreciation 0112123412204370
Profit before tax 335684-012-5-16-58-68
Tax % 34%33%33%33%29%29%-41%28%23%-11%-2%
Net Profit 223463-09-6-14-57-72
EPS in Rs 2.171.431.852.122.261.12-0.093.54-2.29-5.55-19.70-23.24
Dividend Payout % 0%50%38%34%32%90%-1,170%42%-44%-18%-5%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2011-20122014-20152019-20202020-20212022-20232023-20242024-2025
YoY Net Profit Growth (%)0.00%33.33%-50.00%-100.00%-166.67%-133.33%-307.14%
Change in YoY Net Profit Growth (%)0.00%33.33%-83.33%-50.00%-66.67%33.33%-173.81%

Zota Health Care Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2011-2012 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:18%
5 Years:25%
3 Years:31%
TTM:72%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-139%
Stock Price CAGR
10 Years:%
5 Years:55%
3 Years:72%
1 Year:93%
Return on Equity
10 Years:%
5 Years:-15%
3 Years:-24%
Last Year:-36%

Last Updated: September 5, 2025, 1:56 pm

Balance Sheet

Last Updated: December 4, 2025, 2:15 am

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 71012141825252525262931
Reserves 5344514442645564195285
Borrowings 3655000154595140181
Other Liabilities 510141721201935334376109
Total Liabilities 20293540908885139158228439606
Fixed Assets 810981015142962103185251
CWIP 000020003567
Investments 000016141033855492
Other Assets 121926326359617785116193256
Total Assets 20293540908885139158228439606

Reserves and Borrowings Chart

Cash Flow

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 35-36-113-2-6-50
Cash from Investing Activity + -1-19-44-2715-13-92
Cash from Financing Activity + -2-4-6-3-214-1419145
Net Cash Flow 00-1-111-1-03
Free Cash Flow 24-6-1-210-13-23-96
CFO/OP 78%81%-12%147%-134%115%2%-59%811%

Free Cash Flow

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow1.00-1.001.003.008.005.001.000.00-38.00-87.00-146.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2011Mar 2012Mar 2014Mar 2015Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 757179779511299102735550
Inventory Days 122141134175208139140121183201281
Days Payable 779000104827778116126113
Cash Conversion Cycle 120123212251199169161145140131219
Working Capital Days 10270788017515214310811175100
ROCE %20%32%6%-2%15%-2%-7%-17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 68.12%68.12%66.16%66.15%66.15%64.44%62.40%62.02%59.72%57.42%55.81%50.64%
FIIs 0.00%0.04%0.02%0.00%0.00%0.01%0.01%0.24%0.87%3.82%3.49%8.09%
DIIs 0.00%0.00%0.00%0.00%0.00%0.00%0.99%1.03%3.08%4.25%4.95%7.22%
Public 31.88%31.84%33.83%33.85%33.85%35.55%36.60%36.71%36.33%34.52%35.75%34.06%
No. of Shareholders 7,2337,1077,2857,5897,4357,6618,9379,76310,38910,35411,85513,185

Shareholding Pattern Chart

No. of Shareholders

Zota Health Care Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
WhiteOak Capital Special Opportunities Fund 97,721 0.91 12.59N/AN/AN/A
WhiteOak Capital Pharma and Healthcare Fund 33,071 0.87 4.2644,0052026-02-22 07:09:42-24.85%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -20.68-5.59-2.293.58-0.09
Diluted EPS (Rs.) -19.06-5.47-2.293.58-0.09
Cash EPS (Rs.) -4.732.222.465.001.21
Book Value[Excl.RevalReserv]/Share (Rs.) 78.1134.8131.9435.6226.99
Book Value[Incl.RevalReserv]/Share (Rs.) 78.1134.8131.9435.6226.99
Revenue From Operations / Share (Rs.) 102.3169.8355.6352.1443.48
PBDIT / Share (Rs.) -1.283.373.696.530.76
PBIT / Share (Rs.) -16.36-4.40-1.065.07-0.52
PBT / Share (Rs.) -20.13-6.25-1.864.94-0.14
Net Profit / Share (Rs.) -19.81-5.55-2.293.54-0.08
NP After MI And SOA / Share (Rs.) -19.70-5.55-2.293.54-0.08
PBDIT Margin (%) -1.254.826.6312.521.76
PBIT Margin (%) -15.99-6.30-1.909.72-1.20
PBT Margin (%) -19.67-8.95-3.359.47-0.34
Net Profit Margin (%) -19.36-7.94-4.126.78-0.19
NP After MI And SOA Margin (%) -19.25-7.94-4.126.78-0.19
Return on Networth / Equity (%) -25.21-15.94-7.189.93-0.31
Return on Capital Employeed (%) -13.84-7.35-2.2612.36-1.90
Return On Assets (%) -12.84-6.28-3.656.40-0.24
Long Term Debt / Equity (X) 0.020.000.000.000.00
Total Debt / Equity (X) 0.020.160.000.000.00
Asset Turnover Ratio (%) 0.870.930.941.251.23
Current Ratio (X) 1.831.512.082.143.36
Quick Ratio (X) 0.770.781.051.331.81
Inventory Turnover Ratio (X) 3.670.260.490.710.75
Dividend Payout Ratio (NP) (%) -4.85-18.01-65.3728.24-1175.68
Dividend Payout Ratio (CP) (%) -20.7645.0561.0220.0082.97
Earning Retention Ratio (%) 104.85118.01165.3771.761275.68
Cash Earning Retention Ratio (%) 120.7654.9538.9880.0017.03
Interest Coverage Ratio (X) -0.331.823.6251.2217.16
Interest Coverage Ratio (Post Tax) (X) -4.26-2.00-1.4628.78-10.27
Enterprise Value (Cr.) 2311.571240.13707.78746.47338.81
EV / Net Operating Revenue (X) 7.896.875.065.693.17
EV / EBITDA (X) -630.73142.3776.1745.44179.81
MarketCap / Net Operating Revenue (X) 7.876.805.075.713.19
Retention Ratios (%) 104.85118.01165.3771.751275.68
Price / BV (X) 10.3113.638.828.355.13
Price / Net Operating Revenue (X) 7.876.805.075.713.19
EarningsYield -0.02-0.01-0.010.010.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Zota Healthcare Ltd. is a Public Limited Listed company incorporated on 12/07/2000 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ2000PLC038352 and registration number is 038352. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 257.28 Cr. and Equity Capital is Rs. 28.64 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsZota House, 2/896, Surat Gujarat 395002Contact not found
Management
NamePosition Held
Mr. Ketankumar Chandulal ZotaNon Executive Chairman
Mr. Moxesh Ketanbhai ZotaManaging Director
Mr. Laxmi Kant SharmaExecutive Director
Mr. Himanshu Muktilal ZotaWhole Time Director
Mr. Kamlesh Rajnikant ZotaWhole Time Director
Mr. Viren Manukant ZotaWhole Time Director
Mrs. Jaysheeben Nileshkumar MehtaInd. Non-Executive Director
Mrs. Bhumi Maulik DoshiInd. Non-Executive Director
Dr.(Mrs.) Varsaben Gaurang MehtaInd. Non-Executive Director
CA. Dhaval Chandubhai PatwaInd. Non-Executive Director
CA. Vitrag Sureshkumar ModiInd. Non-Executive Director
Dr. Dhiren Prafulbhai ShahInd. Non-Executive Director

FAQ

What is the intrinsic value of Zota Health Care Ltd and is it undervalued?

As of 09 April 2026, Zota Health Care Ltd's intrinsic value is ₹141.20, which is 87.35% lower than the current market price of ₹1,116.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (36.0 %), book value (₹93.5), dividend yield (0.09 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Zota Health Care Ltd?

Zota Health Care Ltd is trading at ₹1,116.00 as of 09 April 2026, with a FY2026-2027 high of ₹1,740 and low of ₹752. The stock is currently in the middle of its 52-week range. Market cap stands at ₹3,802 Cr..

How does Zota Health Care Ltd's P/E ratio compare to its industry?

Zota Health Care Ltd has a P/E ratio of , which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Zota Health Care Ltd financially healthy?

Key indicators for Zota Health Care Ltd: ROCE of 17.0 % indicates efficient capital utilization; ROE of 36.0 % shows strong shareholder returns. Dividend yield is 0.09 %.

Is Zota Health Care Ltd profitable and how is the profit trend?

Zota Health Care Ltd reported a net profit of ₹-57 Cr in Mar 2025 on revenue of ₹292 Cr. Compared to ₹9 Cr in Mar 2022, the net profit shows a declining trend.

Does Zota Health Care Ltd pay dividends?

Zota Health Care Ltd has a dividend yield of 0.09 % at the current price of ₹1,116.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Zota Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports